273 related articles for article (PubMed ID: 17266078)
1. Barriers in the management of glucocorticoid-induced osteoporosis.
Guzman-Clark JR; Fang MA; Sehl ME; Traylor L; Hahn TJ
Arthritis Rheum; 2007 Feb; 57(1):140-6. PubMed ID: 17266078
[TBL] [Abstract][Full Text] [Related]
2. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Cruse LM; Valeriano J; Vasey FB; Carter JD
J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.
Solomon DH; Katz JN; Cabral D; Patrick AR; Bukowski JF; Coblyn JS
Arthritis Rheum; 2006 Dec; 55(6):873-7. PubMed ID: 17139663
[TBL] [Abstract][Full Text] [Related]
5. Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial.
Solomon DH; Katz JN; La Tourette AM; Coblyn JS
Arthritis Rheum; 2004 Jun; 51(3):383-7. PubMed ID: 15188323
[TBL] [Abstract][Full Text] [Related]
6. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
Blalock SJ; Norton LL; Patel RA; Dooley MA
Arthritis Rheum; 2005 Oct; 53(5):732-9. PubMed ID: 16208664
[TBL] [Abstract][Full Text] [Related]
7. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
Ledwich LJ; Clarke K
J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.
McKeown E; Bykerk VP; De Leon F; Bonner A; Thorne C; Hitchon CA; Boire G; Haraoui B; Ferland DS; Keystone EC; Pope JE;
Rheumatology (Oxford); 2012 Sep; 51(9):1662-9. PubMed ID: 22539481
[TBL] [Abstract][Full Text] [Related]
9. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
Benucci M; Dolenti S; Saviola G; Manfredi M
Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-induced osteoporosis preventive care in rheumatology patients.
Koller G; Katz S; Charrois TL; Ye C
Arch Osteoporos; 2019 Feb; 14(1):16. PubMed ID: 30723883
[TBL] [Abstract][Full Text] [Related]
11. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
Curtis JR; Westfall AO; Allison J; Becker A; Melton ME; Freeman A; Kiefe CI; MacArthur M; Ockershausen T; Stewart E; Weissman N; Saag KG
Arch Intern Med; 2007 Mar; 167(6):591-6. PubMed ID: 17389291
[TBL] [Abstract][Full Text] [Related]
12. Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city.
Caballero-Uribe CV; Acosta-Velez JG; Hernandez-Ruiz EA; Andrade Rodado FM; PeƱuela-Epalza M
J Clin Rheumatol; 2008 Jun; 14(3):153-5. PubMed ID: 18525434
[TBL] [Abstract][Full Text] [Related]
13. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).
Majumdar SR; Lix LM; Yogendran M; Morin SN; Metge CJ; Leslie WD
J Clin Endocrinol Metab; 2012 Apr; 97(4):1236-42. PubMed ID: 22298803
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
Gera C; Vij AS
Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351
[TBL] [Abstract][Full Text] [Related]
15. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
Suzuki Y; Sato S
Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275
[TBL] [Abstract][Full Text] [Related]
16. Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.
Feldstein AC; Elmer PJ; Nichols GA; Herson M
Osteoporos Int; 2005 Dec; 16(12):2168-74. PubMed ID: 16142501
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.
Abadie EC; Devogealer JP; Ringe JD; Ethgen DJ; Bouvenot GM; Kreutz G; Laslop A; Orloff JJ; Vanderauwera PM; Delmas PD; Dere WH; Branco J; Altman RD; Avouac BP; Menkes CJ; Vanhaelst L; Mitlak BH; Tsouderos Y; Reginster JY
Semin Arthritis Rheum; 2005 Aug; 35(1):1-4. PubMed ID: 16084217
[TBL] [Abstract][Full Text] [Related]
18. The disconnect between better quality of glucocorticoid-induced osteoporosis preventive care and better outcomes: a population-based cohort study.
Majumdar SR; Lix LM; Morin SN; Yogendran M; Metge CJ; Leslie WD
J Rheumatol; 2013 Oct; 40(10):1736-41. PubMed ID: 23818715
[TBL] [Abstract][Full Text] [Related]
19. Prevention and management of glucocorticoid-induced osteoporosis.
Lane NE; Mroczkowski PJ; Hochberg MC
Bull Rheum Dis; 1995 Aug; 44(5):1-4. PubMed ID: 7550788
[No Abstract] [Full Text] [Related]
20. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
Tanana I; Oshima H
Clin Calcium; 2006 Nov; 16(11):1851-7. PubMed ID: 17079852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]